 ticlopidin treatment progress nonprolif diabet retinopathi timad studi group ticlopidin microangiopathi diabet studi timad double-mask placebo-control trial effect antiplatelet agent ticlopidin hydrochlorid progress nonprolif diabet retinopathi patient year mean yearli increas definit microaneurysm fluorescein angiogram placebo group ticlopidin group signific primari analysi qualiti angiograph coeffici definit microaneurysm patient readabl angiogram period ticlopidin benefici insulin-tr diabet patient sevenfold reduct yearli microaneurysm progress placebo insulin-tr diabet patient develop new vessel ticlopidin group placebo group borderlin statist signific overal retinopathi progress sever ticlopidin group advers reaction ticlopidin neutropenia sever patient clinic complic diarrhea rash studi ticlopidin progress nonprolif diabet retinopathi